Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Clinically proven to visibly reduce discoloration and help prevent future pigment formation, the new serum marks a major advancement in biotech skincare innovation. Powered by patented MI9™ peptide, ...
Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.
According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative ...
Biomedical and PolyPeptide Laboratories announced the signing of a collaboration agreement aimed at providing an integrated, ...
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global ...
Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback